Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties. / Christiansen, Elisabeth; Urban, Christian; Grundmann, Manuel; Due-Hansen, Maria Elisabeth; Hagesaether, Ellen; Schmidt, Johannes; Pardo, Leonardo; Ullrich, Susanne; Kostenis, Evi; Kassack, Matthias U; Ulven, Trond.
I: Journal of Medicinal Chemistry, Bind 54, Nr. 19, 2011, s. 6691-6703.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties
AU - Christiansen, Elisabeth
AU - Urban, Christian
AU - Grundmann, Manuel
AU - Due-Hansen, Maria Elisabeth
AU - Hagesaether, Ellen
AU - Schmidt, Johannes
AU - Pardo, Leonardo
AU - Ullrich, Susanne
AU - Kostenis, Evi
AU - Kassack, Matthias U
AU - Ulven, Trond
PY - 2011
Y1 - 2011
N2 - The free fatty acid receptor 1 (FFA1, also known as GPR40) enhances glucose-stimulated insulin secretion from pancreatic ß-cells and is recognized as an interesting new target for treatment of type 2 diabetes. Several series of selective FFA1 agonists are already known. Most of these are derived from free fatty acids (FFAs) or glitazones, and are relatively lipophilic. Aiming at the development of potent, selective and less lipophilic FFA1 agonists, the terminal phenyl of a known compound series was replaced by nitrogen containing heterocycles. This resulted in the identification of 37, a selective FFA1 agonist with potent activity on recombinant human FFA1 receptors and on the rat insulinoma cell line INS-1E, optimal lipophilicity and excellent in vitro permeability and metabolic stability.
AB - The free fatty acid receptor 1 (FFA1, also known as GPR40) enhances glucose-stimulated insulin secretion from pancreatic ß-cells and is recognized as an interesting new target for treatment of type 2 diabetes. Several series of selective FFA1 agonists are already known. Most of these are derived from free fatty acids (FFAs) or glitazones, and are relatively lipophilic. Aiming at the development of potent, selective and less lipophilic FFA1 agonists, the terminal phenyl of a known compound series was replaced by nitrogen containing heterocycles. This resulted in the identification of 37, a selective FFA1 agonist with potent activity on recombinant human FFA1 receptors and on the rat insulinoma cell line INS-1E, optimal lipophilicity and excellent in vitro permeability and metabolic stability.
U2 - 10.1021/jm2005699
DO - 10.1021/jm2005699
M3 - Journal article
VL - 54
SP - 6691
EP - 6703
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
SN - 0022-2623
IS - 19
ER -
ID: 189162096